DOD Tuberous Sclerosis Complex Clinical and Translational Research Award

The TSCRP Clinical and Translational Research Award mechanism is being offered for the first time in FY09. Important aspects of this award mechanism are as follows: 1. Preliminary Data: Preliminary data relevant to the proposed project are required. 2. Optional Qualified Collaborator: The FY09 TSCRP strongly supports collaborative research. Collaborations that bring new perspectives from other disciplines or bring new investigators into the TSC field are strongly encouraged. Collaborations that meet the criteria below will qualify for a higher level of funding as described in Section I.D. For the application to qualify for the higher level of funding, the Principal Investigator (PI) must submit a Statement of Collaboration that clearly identifies the collaborating investigator and addresses how each of the criteria below are met. Additionally, the collaborator must provide a letter of collaboration describing their involvement in the application. It should be DOD Tuberous Sclerosis Complex Clinical and Translational Research Award 3 clear that the success of the project depends on the unique skills and contributions of each partner. • The collaborator must significantly contribute to the project such that the proposed work could not be accomplished without his/her involvement. • Either the PI or the Collaborator must have TSC research experience as demonstrated through publications and/or funding history. • The collaborator must be at or above the level of Assistant Professor (or equivalent). • At least a 10% level of effort is required of the collaborator. Contribution of the collaborator should be reflected in the application’s budget. 3. This award may support either clinical/translational research studies or (a) Clinical/Translational Studies clinical trials. Each application may only include one of these types of studies. Refer to the Application Instructions and General Information, Appendix 6, for helpful information about distinguishing clinical trials and clinical research. See the Program Announcement for the full Funding Opportunity Description.